Nasal Strips (Flair)

Flair nasal strips represent an innovative mechanical approach to supporting respiratory function in performance horses, particularly those affected by or at risk for exercise-induced pulmonary hemorrhage. Unlike pharmaceutical interventions that work through biochemical mechanisms, Flair strips function as external nasal dilators that physically support the soft tissues of the nasal passages to reduce airway resistance during the intense respiratory demands of athletic performance. This non-pharmacological approach has gained widespread acceptance in the racing and performance horse industries as both a standalone intervention and a complement to other EIPH management strategies.

The mechanism of action of Flair nasal strips is elegantly simple yet physiologically significant. During intense exercise, horses experience dramatic increases in respiratory rate and airflow velocity, which can cause the compliant nasal passages to partially collapse under negative pressure. This dynamic airway obstruction increases the work of breathing and may contribute to the development of EIPH by forcing the horse to generate greater negative intrathoracic pressures. Flair strips counteract this tendency by providing mechanical support to the external nasal structures, maintaining optimal airway patency throughout the respiratory cycle even during maximal exertion.

Flair strips are designed specifically for equine nasal anatomy and consist of flexible spring bands embedded within an adhesive backing material. The strips are applied externally over the nasal passages where they provide gentle outward support to the nasal walls. The adhesive is formulated to maintain secure attachment during intense exercise and sweating while allowing easy removal after performance without causing skin irritation or hair loss. Each strip is designed for single use and should be discarded after removal.

The safety profile of Flair nasal strips is exceptional, as they represent a completely external, non-invasive intervention with no systemic effects. There are no drug interactions, no metabolic processing requirements, and no concerns about organ toxicity. This makes Flair strips an attractive option for trainers and owners who prefer to minimize pharmaceutical interventions or who need compliant options for horses competing under restrictive medication rules. The strips can be used safely in combination with virtually any other EIPH management strategy, from bioflavonoid supplementation to furosemide administration where permitted.

The primary indication for Flair nasal strips in horses is the management and prevention of exercise-induced pulmonary hemorrhage in performance horses engaged in strenuous athletic activities. EIPH affects a substantial majority of racehorses and many other equine athletes, resulting from the extreme cardiovascular and respiratory demands of intense exercise. By reducing upper airway resistance, Flair strips help decrease the magnitude of negative intrathoracic pressures that contribute to pulmonary capillary rupture. This mechanical support addresses one component of the complex pathophysiology underlying EIPH.

The relationship between upper airway function and EIPH development has been elucidated through research demonstrating that horses with dynamic airway obstruction experience greater negative pressure swings in the thorax during exercise. These pressure fluctuations are transmitted to the pulmonary vasculature, where they can contribute to capillary stress and rupture. Flair strips reduce the contribution of nasal passage collapse to this pressure dynamic, potentially decreasing the severity or frequency of bleeding episodes in susceptible horses. Studies have documented measurable reductions in airway resistance and cardiac workload in horses wearing nasal strips during exercise.

Beyond their primary application for EIPH support, Flair nasal strips may benefit horses with other conditions affecting upper airway function. Horses with anatomical variations that predispose to nasal flutter or collapse, such as narrow nasal passages or weak cartilaginous support, may show improved respiratory efficiency with strip application. Some trainers use Flair strips during training sessions as well as competition to reduce cumulative respiratory stress and potentially decrease long-term airway damage from repeated high-intensity exercise.

Flair strips are commonly selected for horses competing under medication restrictions that limit or prohibit the use of furosemide or other pharmaceutical EIPH interventions. Many racing jurisdictions have implemented furosemide-free racing programs, and Flair strips offer a legal alternative for supporting respiratory function in these contexts. The strips have been approved for use by most major racing authorities and equestrian governing bodies, though trainers should verify compliance with specific competition rules before use.

The decision to use Flair nasal strips may be influenced by factors including the horse's history of EIPH, response to other interventions, competitive requirements, and owner preferences regarding pharmaceutical use. Horses with documented bleeding may benefit from Flair strips as part of a comprehensive management program, while horses without known EIPH may use them prophylactically during particularly demanding performances. Veterinary consultation can help determine appropriate application of nasal strip therapy for individual horses.

The application protocol for Flair nasal strips follows specific guidelines designed to ensure optimal adhesion, proper positioning, and maximum effectiveness during exercise. Unlike pharmaceutical agents that require weight-based dosing calculations, Flair strips are sized to fit standard equine nasal anatomy and are applied using consistent technique regardless of horse size. However, proper application is crucial for achieving the intended respiratory benefits, and trainers should familiarize themselves thoroughly with correct technique before using strips in competition settings.

Flair strips are typically applied shortly before exercise or competition, with most manufacturers recommending application within thirty minutes to one hour of anticipated performance. The timing allows for optimal adhesive bonding while ensuring the strip remains securely attached throughout the exercise period. Some trainers prefer to apply strips immediately before entering the starting gate or warm-up ring, while others apply earlier to allow the horse to acclimate to the sensation. Individual preference and experience guide timing decisions within the recommended window.

The duration of Flair strip use corresponds to the exercise or competition period, with strips remaining in place from application through completion of athletic activity. Strips should be removed promptly after exercise to allow normal nasal function to resume and to prevent any potential irritation from prolonged adhesive contact. Each strip is designed for single use only, and attempting to reapply used strips is not recommended as adhesive effectiveness and structural integrity are compromised after removal.

Proper application technique begins with ensuring the nasal area is clean, dry, and free of dirt, sweat, or grooming products that could interfere with adhesion. The strip should be positioned across the nose at the level of the nasal passages, typically at the widest part of the nose where the spring mechanism can provide maximum support to the nasal walls. The adhesive backing is pressed firmly against the hair and skin, with particular attention to ensuring contact along the entire length of the strip. Proper placement positions the supporting springs over the soft tissue areas that are most prone to collapse during exercise.

If a strip is improperly applied or becomes dislodged before exercise, it should be removed and replaced with a fresh strip rather than attempting repositioning. The adhesive is designed for single application, and attempting to reposition a partially attached strip will likely result in inadequate adhesion during exercise. Trainers should keep spare strips available to address application problems or unexpected dislodgement.

There is no equivalent of a missed dose with Flair strips, as they are applied on an as-needed basis for specific exercise sessions rather than administered on ongoing schedules. However, consistent use during training and competition sessions is recommended for horses with documented EIPH to provide regular respiratory support during periods of cardiovascular stress. The decision regarding frequency of use should be made in consultation with a veterinarian based on the individual horse's condition and competition schedule.

The side effect profile of Flair nasal strips is remarkably benign, reflecting their status as external mechanical devices with no systemic absorption or pharmacological activity. Most horses tolerate nasal strip application and wear without any observable adverse effects. The non-invasive nature of the intervention means that concerns about drug toxicity, organ effects, or systemic complications simply do not apply. This exceptional safety profile makes Flair strips appropriate for virtually any horse without the medical screening typically required for pharmaceutical interventions.

The most commonly reported adverse effect associated with Flair strip use is minor skin irritation at the application site in sensitive individuals. This manifests as temporary redness or mild inflammation of the skin beneath the adhesive, typically resolving within hours of strip removal without intervention. Horses with particularly sensitive skin or those with pre-existing dermatological conditions may be more prone to local irritation. Using proper application technique on clean, dry skin and removing strips promptly after exercise minimizes the likelihood of skin reactions.

Some horses may initially react to the unfamiliar sensation of wearing a nasal strip, displaying head shaking, rubbing, or attempts to dislodge the strip. These behavioral responses typically diminish rapidly as the horse becomes accustomed to the feeling, and most horses show complete acceptance within one or two applications. Introducing strips during low-stress training sessions before using them in competition allows horses to acclimate without the added pressure of performance situations. Horses that persistently resist strip wear may have underlying nasal sensitivity that warrants veterinary evaluation.

Serious adverse effects from Flair nasal strip use are essentially unreported in the veterinary literature. The theoretical concern of adhesive-related allergic reactions exists with any adhesive product, but clinically significant allergic responses to Flair strips appear to be extremely rare. Signs of allergic reaction would include marked swelling, hives, or respiratory distress, and any horse showing such signs should have the strip removed immediately with veterinary consultation if symptoms persist.

Long-term use of Flair nasal strips during a horse's competitive career has not been associated with any cumulative adverse effects on nasal tissue or respiratory function. Unlike some interventions that may lose effectiveness or cause tissue changes with repeated use, nasal strips continue to function consistently throughout their service life with no adaptation or tolerance development. This makes them suitable for ongoing use throughout a performance horse's career as needed.

Absolute contraindications to Flair nasal strip use are few due to the non-invasive, external nature of the device. However, certain conditions warrant avoidance or careful consideration before application. Horses with open wounds, active skin infections, or significant dermatological conditions affecting the nasal area should not have strips applied until these conditions have resolved. Applying adhesive strips over compromised skin could worsen existing problems or introduce infection, and adequate adhesion may not be achievable on abnormal skin surfaces.

Horses with known hypersensitivity to adhesive products may not be suitable candidates for Flair strip use. While true adhesive allergies are uncommon, horses that have previously demonstrated reactions to bandage adhesives, fly mask attachments, or similar products should be approached cautiously. Testing strip adhesion on a small area of less sensitive skin before nasal application may help identify horses likely to react adversely, though the nasal area may respond differently than test sites.

Structural abnormalities of the nasal passages that would prevent proper strip positioning or function may represent contraindications to use. Horses with congenital nasal deformities, previous nasal surgery, or significant trauma affecting nasal anatomy may not achieve the intended support from standard strip application. Veterinary evaluation can help determine whether nasal strips are appropriate for horses with unusual nasal anatomy and whether modified application techniques might be beneficial.

Certain competition contexts may effectively contraindicate Flair strip use despite their general regulatory acceptance. While most major racing and equestrian authorities permit nasal strips, some specific events or jurisdictions may have restrictions. Trainers must verify compliance with applicable rules before using strips in competition, as inadvertent rule violations can result in penalties or disqualification. Additionally, horses that become severely distressed during strip application despite acclimation attempts may not be appropriate candidates, as the stress of application could outweigh potential respiratory benefits.

Flair nasal strips do not interact with medications in the traditional pharmacological sense, as they have no systemic absorption and function through purely mechanical means. This absence of drug interactions represents one of the significant advantages of nasal strips over pharmaceutical EIPH interventions. Horses receiving any medication regimen can safely use Flair strips without concerns about altered drug metabolism, synergistic toxicity, or therapeutic interference. The strips can be confidently combined with any treatment protocol.

The combination of Flair nasal strips with furosemide represents the most common concurrent use scenario in EIPH management. These two interventions work through entirely different mechanisms and provide complementary support for horses with significant bleeding. Furosemide reduces pulmonary vascular pressures through its diuretic effect, while Flair strips reduce upper airway resistance. Many trainers in jurisdictions permitting furosemide use employ both interventions simultaneously to maximize EIPH protection through multiple pathways.

Flair strips are commonly used in conjunction with nutritional supplements marketed for vascular support and EIPH management. Products containing bioflavonoids, vitamin C, omega-3 fatty acids, and other compounds intended to strengthen capillary integrity pose no interaction concerns when combined with mechanical nasal support. This allows trainers to develop comprehensive EIPH management programs incorporating multiple approaches without limitation.

Competition-related considerations regarding concurrent use primarily involve ensuring compliance with applicable medication rules rather than pharmacological interactions. When Flair strips are used alongside permitted medications in competition, standard withdrawal time calculations for those medications remain unchanged. The strips themselves require no withdrawal period and can be applied immediately before competition regardless of other treatment history. Trainers should maintain complete records of all interventions used in competition horses for regulatory compliance purposes.

Monitoring requirements for Flair nasal strip use focus on proper application technique and detection of any local irritation rather than systemic health parameters. Trainers should observe the strip position throughout exercise when possible to ensure it remains properly placed, as dislodgement would eliminate the intended respiratory benefits. Post-exercise inspection of the application site should note any redness, irritation, or skin reaction that might influence future use decisions. General observation of the horse's respiratory effort and recovery after exercise provides feedback on strip effectiveness.

Special populations within the equine community require minimal additional considerations for nasal strip use compared to pharmaceutical interventions. Foals and young horses can safely wear nasal strips when appropriately sized, though most manufacturers produce strips designed for mature horse dimensions. Geriatric horses experience no increased risk from strip use and may benefit from respiratory support if declining fitness results in increased airway effort during exercise. Pregnant mares have no contraindication to nasal strip use, though exercise itself may be limited during late gestation.

Competition regulations regarding Flair nasal strips vary among governing bodies and have evolved over time. Most major racing jurisdictions in North America, Europe, and internationally now permit nasal strip use, recognizing their mechanical rather than pharmacological nature. However, trainers must verify current rules for specific competitions, as regulations can change and may vary between venues or race types. Some historic or traditional events may prohibit strips for aesthetic reasons despite their physiological acceptability. The FEI and USEF have established positions on nasal strip use in their respective disciplines.

Application technique precautions include ensuring appropriate skin preparation and avoiding application to wet or dirty surfaces. Trainers should not apply strips over any topical medications, liniments, or grooming products in the nasal area. Care should be taken to avoid getting adhesive in the horse's eyes or nostrils during application. Strip removal should be performed gently, pulling in the direction of hair growth to minimize discomfort and reduce hair loss.

Long-term use considerations for Flair strips are minimal due to their external, non-absorbed nature. Horses can safely use strips throughout their competitive careers without concerns about cumulative effects or tolerance development. However, horses with recurrent skin irritation at the application site may require breaks between uses or alternative EIPH management approaches. Regular veterinary evaluation of horses with EIPH ensures that nasal strip use remains appropriate as part of the overall management strategy.

Proper storage of Flair nasal strips maintains adhesive integrity and ensures optimal performance when applied. Strips should be stored in their original packaging in a cool, dry environment away from direct sunlight and temperature extremes. Excessive heat can cause the adhesive to become overly soft and may affect bonding strength, while very cold temperatures could make the strip material less flexible. Room temperature storage conditions, typically between 15 and 25 degrees Celsius, are appropriate for most environments. Tack rooms and equipment storage areas are generally suitable provided they do not experience extreme temperature fluctuations.

Handling Flair strips requires attention to maintaining adhesive surface cleanliness until application. The protective backing should remain in place until immediately before strip placement to prevent contamination of the adhesive with dirt, debris, or handling oils. Trainers should handle strips by their edges when removing from packaging to avoid touching the adhesive surface. Strips that have been dropped, contaminated, or have had their adhesive surface exposed for extended periods should be discarded rather than applied, as compromised adhesion could result in strip loss during competition.

Safe handling practices for humans working with Flair strips are straightforward. The materials used in strip construction do not pose toxicity concerns, and standard hygiene practices are sufficient. Washing hands after application is recommended primarily to remove any residual adhesive rather than for safety reasons. The strips contain no hazardous materials requiring special handling, protective equipment, or disposal procedures.

Expiration dating on Flair strip packages should be respected to ensure optimal adhesive performance. While strips do not contain active pharmaceutical ingredients subject to degradation, the adhesive compounds have finite shelf lives after which bonding strength may be compromised. Using expired strips risks inadequate adhesion and potential loss during competition. Disposal of expired or used strips follows standard waste handling procedures with no environmental concerns requiring special consideration. Trainers should purchase strip quantities appropriate for their anticipated use schedule to minimize waste from expiration.

Draft horses and other large breeds may require consideration of nasal strip sizing, as their broader nasal structures could affect optimal positioning and support distribution. While standard Flair strips are designed to fit typical light horse anatomy, the larger nasal dimensions of draft breeds may result in different mechanical effects. However, draft horses are rarely engaged in the types of high-speed exercise most associated with EIPH, making nasal strip use less commonly indicated in these breeds. For draft horses in driving competitions or other strenuous activities, proper strip placement should be evaluated on an individual basis.

Thoroughbreds and Standardbreds represent the breeds most commonly using Flair nasal strips due to their predominance in racing where EIPH prevalence is highest and nasal strip use is most established. The strips are specifically designed with these breeds' nasal anatomy in mind, and most research validating nasal strip effectiveness has been conducted in racing populations. Quarter Horses competing in racing, barrel racing, and other speed events also commonly use nasal strips following similar protocols established in Thoroughbred racing.

Ponies and miniature horses present sizing considerations that may affect Flair strip applicability. Standard equine nasal strips may be too large for proper positioning on smaller equine faces, potentially resulting in inadequate support or improper placement. Some manufacturers offer sizing variations that may be more appropriate for ponies. Miniature horses rarely engage in exercise intensities associated with EIPH development, making nasal strip indication in this population uncommon.

Breed-specific variations in nasal anatomy beyond size may influence strip effectiveness. Breeds with convex facial profiles or pronounced nasal bones may experience different mechanical support characteristics compared to breeds with straight or concave profiles. Arabian horses, with their distinctive dished facial conformation and relatively small nostrils, may require attention to strip placement to achieve optimal results. Warmbloods competing in upper-level eventing experience cardiovascular demands that can result in EIPH and may benefit from nasal strips sized appropriately for their typically larger heads compared to Thoroughbreds.

Within the category of mechanical respiratory aids, Flair nasal strips occupy a unique position as the most widely used and researched option. Alternative nasal dilator designs have been developed but have not achieved the same level of acceptance or regulatory approval as the Flair brand. Nasal cannulas or tubes that mechanically hold the nasal passages open represent a different approach to achieving similar goals but are less commonly used due to practical application challenges and potential for displacement during exercise.

Pharmaceutical alternatives for EIPH management include furosemide as the most commonly used medication in jurisdictions where it remains permitted. Furosemide works through systemic diuretic effects to reduce pulmonary vascular pressures, contrasting with the mechanical local action of nasal strips. Other pharmaceutical options include aminocaproic acid and tranexamic acid, which work through effects on the coagulation cascade. These pharmaceutical approaches are subject to regulatory restrictions that do not apply to mechanical devices like nasal strips.

Complementary therapies commonly combined with Flair nasal strips include bioflavonoid supplementation, omega-3 fatty acid administration, and environmental management strategies. Many trainers employ multimodal approaches that incorporate nasal strips alongside nutritional support for vascular integrity. Optimization of barn environment to minimize dust and respiratory irritants, along with appropriate conditioning programs that gradually develop cardiovascular fitness, complement the acute respiratory support provided by nasal strips during exercise. Veterinary guidance should direct the integration of various EIPH management approaches for individual horses based on bleeding severity, competitive requirements, and response to interventions.